INTHERA BIOSCIENCE
Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform. The company is headquartered in Zürich, Switzerland.
INTHERA BIOSCIENCE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.intherabio.com
Total Employee:
11+
Status:
Active
Total Funding:
20.06 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins IPv6 Microsoft LiteSpeed
Similar Organizations
AbCheck s.r.o.
AbCheck s.r.o provides a unique source of therapeutic antibodies with one of the industry's most versatile technology platforms.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apex Molecular
Apex Molecular a leading provider of specialist chemistry services to the pharmaceutical, biotechnology and applied chemistry sectors.
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Bioithas
Bioithas research is directed at obtaining unique biotechnological results, generating projects with real value.
Carlina Technologies
Company specialized in the development of nanomedicines utilizing innovative controlled drug delivery technology platforms.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
ExtremoChem
ExtremoChem develops small organic molecules, obtained exclusively by chemical synthesis, with protein stabilizing properties.
Feroscan
Development of 1st-in-class personalized organometallic with a unique & innovative mode of action coupled with nanoparticle
Hoba Therapeutics
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
HQS Quantum Simulations
HQS Quantum Simulations is developing quantum algorithms to predict molecular properties for specialty chemicals & pharmaceutical companies.
Icon Bioscience
Icon Bioscience develops and commercializes novel ophthalmic pharmaceuticals through a proprietary drug delivery platform.
Libera Bio
Addressing “undruggable intracellular targets” in oncology
Metis Precision Medicine
Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need.
NanoTemper Technologies
NanoTemper builds tools for challenging characterizations: affinity screening, molecular interactions, protein stability, or protein quality
Osteolabs
Osteolabs brings the possibility for a bone density study significantly ahead in time.
Peptomyc
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Prescient Healthcare Group
Prescient Healthcare Group was founded in London in 1995, originally specializing in competitive insights.
QuantuMDx Group
QuantuMDx is a medical devices company developing handheld and portable diagnostic, genomic sequencing, and proteomic platforms.
Resolve BioSciences
Resolve Biosciences is applying the power of Molecular Cartography to enable scientists to gain new insights in spatial biology.
RS Research
RS Research is a pharmaceutical company developing next generation of nanomedicines based on an innovative drug delivery platform.
Scope Biosciences
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures investment in Series A - Inthera Bioscience
M Ventures
M Ventures investment in Series A - Inthera Bioscience
Novo Holdings
Novo Holdings investment in Series A - Inthera Bioscience
M Ventures
M Ventures investment in Series A - Inthera Bioscience
Novo Holdings
Novo Holdings investment in Series A - Inthera Bioscience
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures investment in Series A - Inthera Bioscience
EVA Basel
EVA Basel investment in Seed Round - Inthera Bioscience
Novo Holdings
Novo Holdings investment in Seed Round - Inthera Bioscience
Microsoft Accelerator
Microsoft Accelerator investment in Seed Round - Inthera Bioscience
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures investment in Seed Round - Inthera Bioscience
Official Site Inspections
http://www.intherabio.com
- Host name: linux31.curanet.dk
- IP address: 185.21.41.237
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
